Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
08/2013
08/20/2013US8513451 Fluorescent phospholipase A2 indicators
08/20/2013US8513437 Pyrrolidino-1,4-naphthoquinone deriviatives and their use for treating malignancies and cardiovascular diseases
08/20/2013US8513289 P38 kinase inhibiting agents
08/20/2013US8513268 1H-quinazoline-2,4-diones processes for their production, pharmaceutical compositions, and treatment for epilepsy
08/20/2013US8513253 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
08/20/2013US8513237 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
08/20/2013US8512597 Polymerizable optically active imide compound and polymerizable composition containing the compound
08/20/2013CA2569729C Peptidomimetic inhibitors of retroviral proteases and their use as antivirals
08/15/2013WO2013117749A1 Pyrrolic derivatives, processes for preparing the same and their uses as a drug
08/15/2013US20130211101 Crystalline Glycopyrrolate Tosylate
08/15/2013US20130211098 Process for preparing 4-amino-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-pentanoic acid compounds
08/15/2013US20130210877 Pharmaceutical compositions comprising poh derivatives
08/15/2013US20130210769 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
08/14/2013EP2626357A1 Pyrrolic derivatives, processes for preparing the same and their uses as antibiotics
08/14/2013EP2625165A1 Insecticidal pyrrolidin-yl-aryl-carboxamides
08/14/2013CN103249717A Improved process for preparation of high molecular weight molybdenum succinimide complexes
08/14/2013CN103249715A Substituted carbamoylcycloalkyl acetic acid derivatives as NEP inhibitors
08/14/2013CN103249484A Catalyst for asymmetric hydrogenation and method for manufacturing optically active carbonyl compound using the same
08/14/2013CN103242262A N-fatty acyl ethanolamine hydrolase inhibitor, as well as synthesis method and application thereof
08/14/2013CN103242213A Method for dehydrating and desalting solution with salt, water and N-methyl-pyrrolidone generated in synthetic process of polyphenylene sulfide
08/14/2013CN103242212A Precursor of brain histamine H3 receptor radioligand and preparation method of precursor
08/14/2013CN103242210A Mulin acetate containing substituted squaric acid and application thereof
08/14/2013CN103242192A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
08/14/2013CN102659656B Method for separating dangshen alkaloid monomers from dangshen through high-speed counter-current chromatography
08/14/2013CN102432515B Preparation technology for N-ethyl pyrrolidine
08/14/2013CN102424663B Atorvastatin amino acid and preparation method thereof
08/14/2013CN102395660B Polyalkylene glycol-based ether pyrrolidone carboxylic acids, and concentrates for the production of synthetic cooling lubricants containing the same
08/14/2013CN101838260B Dihydropyrrolones derivative as Caspase-3 inhibitor
08/14/2013CN101454330B Cosmetic use of hydroxylated amide compound as skin moisturizer
08/13/2013US8507722 Hepatitis C virus inhibitors
08/13/2013US8507537 Trifluromethoxyphenyl-substituted tetramic acid derivatives pesticides and/or herbicides
08/13/2013US8507514 Hydrazide compound and use of the same in pest control
08/08/2013WO2013083975A3 Novel pyrrole derivatives
08/08/2013US20130204001 Process for producing compounds comprising nitrile functions
08/08/2013US20130203815 Cytokine inhibitors
08/08/2013US20130203751 Substituted 8-alkoxy-2-aminotetralin derivatives, and use thereof
08/08/2013US20130203750 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
08/08/2013US20130203738 Use of compound binding to msin3b that specifically binds to neuron restrictive silencer factor (nrsf)
08/08/2013DE112007000484B4 Stabil isotopenmarkierte aliphatische Aminosäuren, Verfahren zum Einbringen von diesen in ein Zielprotein und Verfahren zur NMR-Konformationsanalyse von Proteinen Stable isotope-labeled aliphatic amino acids, methods for introducing these into a target protein, and NMR method for the conformation of proteins
08/07/2013EP2623608A2 Method for preparing 2-pyrrolidone using biomass
08/07/2013EP2621934A1 Electrolyte formulations containing cyano-alkoxy-borate anions
08/07/2013EP2621901A1 Selective androgen receptor modulators
08/07/2013EP2621900A1 Imine substituted 2, 4 - diaryl - pyrroline derivatives as pesticides
08/07/2013EP2621898A1 Process for the preparation of tetracyclic derivatives and intermediate products used in the process
08/07/2013EP2621897A1 Imine compounds
08/07/2013CN103237791A Compositions and methods for the treatment of pathological condition(s) related to GPR35 and/or GPR35-HERG complex
08/07/2013CN103237790A Novel methylcyclohexane derivatives and uses thereof
08/07/2013CN103237789A Imine compounds
08/07/2013CN103237788A Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
08/07/2013CN103232376A Preparation methods of pyrrolinone dye compound and intermediate thereof
08/07/2013CN102469823B Flavoring compositions for savory applications
08/07/2013CN102241618B Method for preparing 1,3,4-trisubstituted or 3,4-disubstituted pyrrole ring compounds
08/07/2013CN101896479B Process for the preparation of pyrido [2,1-a] isoquinoline derivatives
08/06/2013US8501965 Method for producing 3-substituted-4-fluoropyrrolidine derivative
08/06/2013US8501964 Serotonin reuptake inhibitors
08/06/2013US8501963 Process for producing cyclic compounds
08/06/2013US8501937 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support
08/06/2013US8501737 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
08/06/2013CA2646624C Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
08/06/2013CA2612375C Synthetic processes for the preparation of aminocyclohexyl ether compounds
08/06/2013CA2591937C Tetralin and indane derivatives and uses thereof
08/06/2013CA2567513C Histamine h3 receptor agents, preparation and therapeutic uses
08/06/2013CA2563180C Non-nucleoside reverse transcriptase inhibitors
08/01/2013WO2013112878A1 Mcl-1 modulating compositions
08/01/2013WO2013112136A1 Multi-stable electronic inks
08/01/2013US20130197243 Salts of 7-amino-3,5-dihydroxyheptanoic acid esters
08/01/2013US20130197218 Novel stable and highly tunable metathesis catalysts
08/01/2013US20130197059 Integrin antagonist conjugates for targeted delivery to cells expressing lfa-1
08/01/2013US20130196978 Alkaloid aminoester derivatives and medicinal composition thereof
07/2013
07/31/2013EP2620429A1 Hydroxylamine compounds and methods of their use
07/31/2013EP2620428A1 Asymmetric auxiliary group
07/31/2013CN103228764A Composition for improving oil recovery including N-auroyl amino acid-based compounds and microbes
07/31/2013CN103228628A Method for producing 3,4-disubstituted pyrrolidine derivative
07/31/2013CN103228627A Imine substituted 2, 4 -diaryl - pyrroline derivatives as pesticides
07/31/2013CN103224464A Cyclohexene derivative or its pharmaceutically acceptable salt and application thereof
07/31/2013CN102227406B Preparation method of (r)-3- vinyl pyrrolidine-1- tert-butyl methanoic acid and intermediates thereof
07/31/2013CN102060643B Preparation method of N-aryl amino acid
07/31/2013CN102026970B Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
07/31/2013CN101775011B N-substituted phenyl-3-methylene heterocyclic arene-2,5-dimethylpyrrole compound and application thereof in anti-HIV/AIDS
07/30/2013US8497383 HIV protease inhibitors
07/30/2013US8497282 Method of preparing (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
07/30/2013US8497263 Pyrrolinone derivative and pharmaceutical composition comprising the same
07/30/2013US8497232 Friction modifier and transmission oil
07/30/2013CA2611823C Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
07/30/2013CA2599538C N-sulphonylpyrroles and their use as histone deacetylase inhibitors
07/30/2013CA2479764C Hemiasterlin derivatives and uses thereof
07/25/2013WO2013110005A1 Boronate-mediated delivery of molecules into cells
07/25/2013US20130190488 Apoptosis promoters
07/25/2013US20130190377 Novel Lactams
07/25/2013US20130190371 Fungicide Active Substance Combinations
07/25/2013US20130190338 Sulfur derivatives as chemokine receptor modulators
07/25/2013US20130190296 Compositions and methods for the treatment of disease associated with trp-p8 expression
07/24/2013EP2616438A1 Use of n-substituted 2-pyrrolidone-4-carbonic acid esters as solvents
07/24/2013EP2616437A1 Pesticidal arylpyrrolidines
07/24/2013CN103221512A Oil release with n-auroyl amino acid-based compounds
07/24/2013CN103221390A Glycine derivatives and their use as muscarinic receptor antagonists
07/24/2013CN103215321A Process for preparing dipeptidyl iv inhibitors and intermediates therefor
07/24/2013CN103214450A Modulators of atp-binding cassette transporters
07/24/2013CN103214407A Method for preparing pyrrolidine derivative
07/24/2013CN102617435B Leucosceptrum canum chinone, preparation method and application
1 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 ... 404